These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12824911)

  • 21. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi.
    Mathieu A; Remmelink M; D'Haene N; Penant S; Gaussin JF; Van Ginckel R; Darro F; Kiss R; Salmon I
    Cancer; 2004 Oct; 101(8):1908-18. PubMed ID: 15386340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serpin b3 is associated with poor survival after chemotherapy and is a potential novel predictive biomarker in advanced non-small-cell lung cancer.
    Urquhart G; Kerr KM; Nicolson M; Loo PS; Sharma R; Shrimali R; Petty RD
    J Thorac Oncol; 2013 Dec; 8(12):1502-9. PubMed ID: 24389432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
    Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
    Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
    Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
    Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Takayama K; Kiyohara C; Hara N
    Eur J Cancer; 1998 Aug; 34(9):1352-7. PubMed ID: 9849416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.
    Gajra A; Tatum AH; Newman N; Gamble GP; Lichtenstein S; Rooney MT; Graziano SL
    Lung Cancer; 2002 May; 36(2):159-65. PubMed ID: 11955650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.
    Jeong SH; Lee HW; Han JH; Kang SY; Choi JH; Jung YM; Choi H; Oh YT; Park KJ; Hwang SC; Sheen SS; Oh YJ; Kim JH; Lim HY
    Jpn J Clin Oncol; 2008 Oct; 38(10):661-9. PubMed ID: 18772168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.
    Hsu C; Kuo SH; Hu FC; Cheng AL; Shih JY; Yu CJ; Lin CC; Huang TC; Yang PC; Yang CH
    Lung Cancer; 2008 Dec; 62(3):334-43. PubMed ID: 18450322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
    Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
    J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer.
    Chiou JF; Liang JA; Hsu WH; Wang JJ; Ho ST; Kao A
    Lung; 2003; 181(5):267-73. PubMed ID: 14705770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.
    Cortinovis DL; Andriani F; Livio A; Fabbri A; Perrone F; Marcomini B; Pilotti S; Mariani L; Bidoli P; Bajetta E; Roz L; Sozzi G
    Curr Cancer Drug Targets; 2008 Aug; 8(5):342-8. PubMed ID: 18690840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of p21 expression in non-small-cell lung cancer.
    Shoji T; Tanaka F; Takata T; Yanagihara K; Otake Y; Hanaoka N; Miyahara R; Nakagawa T; Kawano Y; Ishikawa S; Katakura H; Wada H
    J Clin Oncol; 2002 Sep; 20(18):3865-71. PubMed ID: 12228206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of the expression of lung resistance protein in non-small cell lung carcinomas].
    Lü M; Wang J; Yi X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):458-60. PubMed ID: 11718033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
    Liu H; Zhang T; Li X; Huang J; Wu B; Huang X; Zhou Y; Zhu J; Hou J
    Cancer Sci; 2008 Nov; 99(11):2185-92. PubMed ID: 18823373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance.
    Volm M; Mattern J; Koomägi R
    Anticancer Drugs; 1997 Nov; 8(10):931-6. PubMed ID: 9436635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
    Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
    Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.